Supplementary Table S2 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma

Supplementary Table S2 from Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma

<p>Supplementary Table S2</p>

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awdur: Phyllis S.Y. Chong (17141520) (author)
Awduron Eraill: Jing-Yuan Chooi (17141523) (author), Julia S.L. Lim (17141526) (author), Aaron C.Y. Leow (17141529) (author), Sabrina Hui Min Toh (17141532) (author), Irfan Azaman (17141535) (author), Mun Yee Koh (17141538) (author), Phaik Ju Teoh (17141541) (author), Tuan Zea Tan (14952532) (author), Tae-Hoon Chung (17141544) (author), Wee Joo Chng (14959944) (author)
Cyhoeddwyd: 2025
Pynciau:
Cancer
Cancer Risk Factors
Molecular and Cellular Biology
Therapeutic Research and Development
Drug Resistance
Clinical drug resistance
Epigenetics
Histone Modification
Metabolism
Metabolomics
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg